Bruker Corporation has announced the successful acceptance of the UK's most powerful 1.2 GHz NMR spectrometer at the University of Warwick, funded by a £17 million grant from UK Research and Innovation (UKRI). This state-of-the-art instrument, featuring Bruker's advanced hybrid magnet technology, will be utilized by UK researchers to advance studies in areas such as materials research, life sciences, energy materials, drug design, and anti-microbial resistance. The spectrometer is part of a collaborative effort supported by UKRI and involves multiple UK universities and the private sector, aiming to deliver groundbreaking science with significant real-world impact.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.